The impact of atherosclerotic renovascular disease on diabetic renal failure

Diabetic Medicine

Volumn 19, Issue 11, 2002, Pages 889-894

  Nicholls, A J ^a  

^a ROYAL DEVON AND EXETER HOSPITAL   (United Kingdom)

Author keywords

Atherosclerosis; Diabetes; Renal failure; Renovascular disease

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IRBESARTAN; LOSARTAN;

ATHEROSCLEROSIS; CLINICAL FEATURE; CLINICAL TRIAL; CREATININE BLOOD LEVEL; DETERIORATION; EMBOLISM; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY ISCHEMIA; LUNG EDEMA; MAGNETIC RESONANCE ANGIOGRAPHY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PREVALENCE; RENOVASCULAR DISEASE; REVASCULARIZATION; REVIEW; STENT; SURVIVAL; TREATMENT OUTCOME;

ARTERIOSCLEROSIS; BALLOON DILATATION; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; HUMANS; KIDNEY FAILURE; PATIENT SELECTION; RENAL ARTERY OBSTRUCTION; REPERFUSION; RISK FACTORS;

EID: 0036432909     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2002.00813.x     Document Type: Review

References (58)

1. Corradi B, Malberti F, Farina M, Cosci P, Imbasciati E, Raieli G et al. Chronic renal failure due to atheromatous renovascular disease in the elderly. Contrib Nephrol 1993; 105: 167-171.
2. Scoble JE, Hamilton G. Atherosclerotic renovascular disease. Remediable cause of renal failure in the elderly. BMJ 1990; 300: 1670-1671.
3. Pattison JM, Reidy JF, Rafferty MJ, Ogg CS, Cameron JS, Sacks SH et al. Percutaneous transluminal renal angioplasty in patients with renal failure. Q J Med 1992; 85: 883-888.
4. Albers FJ. Clinical characteristics of atherosclerotic renovascular disease. Am J Kid Dis 1994; 24: 636-641.
5. Novick AC, Ziegelbaum M, Vidt DG, Gifford RW Jr, Pohl MA, Goormastic M. Trends in surgical revascularization for renal artery disease. Ten years' experience. JAMA 1987; 257: 498-501.
6. Appel RG, Bleyer AJ, Reavis S, Hansen KJ. Renovascular disease in older patients beginning renal replacement therapy. Kidney Int 1995; 48: 171-176.
7. The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high risk patients. N Engl J Med 2000; 342: 145-153.
8. Toto RD. Renal insufficiency due to angiotensin-converting enzyme inhibitors. Min Electrol Metab 1994; 20: 193-200.
9. Kalra PA, Mamtora H, Holmes AM, Waldek S. Renovascular disease and renal complications of angiotensin-converting enzyme inhibitor therapy. Q J Med 1990; 77: 1013-1018.
10. Mailloux LU, Bellucci AG, Mossey RT, Napolitano B, Moore T, Wilkes BM et al. Predictors of survival in patients undergoing dialysis. Am J Med 1988; 84: 855-862.
11. O'Neil EA, Hansen KJ, Canzanello VJ, Pennell TC, Dean RH. Prevalence of ischemic nephropathy in patients with renal insufficiency. Am Surg 1992; 58: 485-490.
12. Zuccala A, Losinno F, Zucchelli A, Zucchelli PC. Renovascular disease in diabetes mellitus: Treatment by percutaneous transluminal renal angioplasty. Nephrol Dial Transplant 1998; 13: 26-29.
13. Valabhji J, Robinson S, Poulter C, Robinson AC, Kong C, Henzen C et al. Prevalence of renal artery stenosis in subjects with type 2 diabetes and coexistent hypertension. Diabetes Care 2000; 23: 539-543.
14. Courreges JP, Bacha J, Aboud E, Pradier P. Prevalence of renal artery stenosis in type 2 diabetes. Diabetes Metab 2000; 26: 90-96.
15. Missouris CG, Buckenham T, Cappuccio FP, MacGregor GA. Renal artery stenosis: A common and important problem in patients with peripheral vascular disease. Am J Med 1994; 96: 10-14.
16. Swartbol P, Thorvinger BO, Parsson H, Norgren L. Renal artery stenosis in patients with peripheral vascular disease and its correlation to hypertension. A retrospective study. Int Angiol 1992; 11: 195-199.
17. Jean WJ, al-Bitar I, Zwicke DL, Port SC, Schmidt DH, Bajwa TK. High incidence of renal artery stenosis in patients with coronary artery disease. Cathet Cardiovasc Diagn 1994; 32: 8-10.
18. Schwartz CJ, White TA. Stenosis of renal artery: An unselected necropsy study. BMJ 1964; ii: 1415-1421.
19. Mather HM, Keen H. The Southall diabetes survey: Prevalence of known diabetes in Asians and Europeans. BMJ 1985; 291: 1081-1084.
20. Frassinetti Fernandes P, Ellis PA, Roderick PJ, Cairns HS, Hicks JA, Cameron JS. Causes of end-stage renal failure in black patients starting renal replacement therapy. Am J Kidney Dis 2000; 36: 301-309.
21. Alhaddad IA, Blum S, Heller EN, Beato MA, Bhalodkar NC, Keriaky GE et al. Renal artery stenosis in minority patients undergoing diagnostic cardiac catheterization: Prevalence and risk factors. J Cardiovasc Pharmacol Ther 2001; 6: 147-153.
22. Novick AC, Zaki S, Goldfarb D, Hodge EE. Epidemiologic and clinical comparison of renal artery stenosis in black patients and white patients. J Vasc Surg 1994; 20: 1-5.
23. Kshirsagar AV, Joy MS, Hogan SL, Falk RJ, Colindres RE. Effect of ace inhibitors in diabetic and nondiabetic chronic renal disease: A systematic overview of randomized placebo-controlled trials. Am J Kidney Dis 2000; 35: 695-707.
24. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703-713.
25. Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001; 345: 851-860.
26. Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving H-Het al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345: 861-869.
27. Bakris G, Weir M. Angiotensin converting enzyme inhibitor associated elevations in serum creatinine. Arch Intern Med 2000; 160: 685-693.
28. Conlon PJ, O'Riordan E, Kalra PA. New insights into the epidemiologic and clinical manifestations of atherosclerotic renovascular disease. Am J Kidney Dis 2000; 35: 573-587.
29. Dean RH, Englund R, Dupont WD, Meacham PW, Plummer WD Jr, Pierce Ret al. Retrieval of renal function by revascularization. Study of preoperative outcome predictors. Ann Surg 1985; 202: 367-375.
30. Gruenewald SM, Collins LT, Antico VF, Farlow DC, Fawdry RM. Can quantitative renography predict the outcome of treatment of atherosclerotic renal artery stenosis? J Nucl Med 1989; 30: 1946-1954.
31. Bedoya L, Ziegelbaum M, Vidt DG, Badhwar K, Novick AC, Gifford RW Jr. Baseline renal function and surgical revascularization in atherosclerotic renal arterial disease in the elderly. Clev Clin J Med 1989; 56: 415-421.
32. Chaikof EL, Smith RBR, Salam AA, Dodson TF, Lumsden AB, Kosinski AS et al. Ischemic nephropathy and concomitant aortic disease: A ten-year experience. J Vasc Surg 1994; 19: 135-46; discussion 46-48.
33. Mercier C, Piquet P, Alimi Y, Tournigand P, Albrand JJ. Occlusive disease of the renal arteries and chronic renal failure: The limits of reconstructive surgery. Ann Vasc Surg 1990; 4: 166-170.
34. Zinman L, Libertino JA. Revascularization of the chronic totally occluded renal artery with restoration of renal function. J Urol 1977; 118: 517-521.
35. Vidt DG, Eisele G, Gephardt GN, Tubbs R, Novick AC. Athero-embolic renal disease: Association with renal arterial stenosis. Clev Clin J Med 1989; 56: 407-413.
36. Chabova V, Schirger A, Stanson AW, McKusick MA, Textor SC. Outcomes of atherosclerotic renal artery stenosis managed without revascularization. Mayo Clin Proc 2000; 75: 437-444.
37. Freedman BI, Iskandar SS, Appel RG. The link between hypertension and nephrosclerosis. Am J Kid Dis 1995; 25: 207-221.
38. Zierler RE, Bergelin RO, Isaacson JA, Strandness DE Jr. Natural history of atherosclerotic renal artery stenosis: A prospective study with duplex ultrasonography. J Vasc Surg 1994; 19: 250-7; discussion 7-8.
39. Schreiber MJ, Pohl MA, Novick AC. The natural history of atherosclerotic and fibrous renal artery disease. Urol Clin N Am 1984; 11: 383-392.
40. Shurrab AE, Mamtora H, O'Donoghue D, Waldek S, Kalra PA. Increasing the diagnostic yield of renal angiography for the diagnosis of atheromatous renovascular disease. Br J Radiol 2001; 74: 213-218.
41. Corradi B, Malberti F, Farina M, Cosci P, Imbasciati E, Raieli G et al. Chronic renal failure due to atheromatous disease in the elderly. Contrib Nephrol 1993; 105: 167-171.
42. Makanjuola A, Suresh M, Laboi P, Kalra PA, Scoble JE et al. Proteinuria in atherosclerotic renovascular disease. Q J Med 1999; 92: 515-518.
43. Lawrence WF, Grist TM, Brazy PC, Fryback DG. Magnetic resonance angiography in progressive renal failure: A technology assessment. Am J Kid Dis 1995; 25: 701-709.
44. Judge JS, Low V, Gajraj H, House AK. The value of technetium-99 m renography for the detection of renal artery stenosis in patients with aortic and lower limb vascular disease. Aust NZ J Surg 1992; 62: 261-265.
45. Berland LL, Koslin DB, Routh WD, Keller FS. Renal artery stenosis: Prospective evaluation of diagnosis with color duplex as compared with angiography. Work in progress. Radiology 1990; 174: 421-423.
46. Devoy MA, Tomson CR, Edmunds ME, Feehally J, Walls J. Deterioration in renal function associated with angiotensin converting enzyme inhibitor therapy is not always reversible. J Int Med 1992; 232: 493-498.
47. Caps MT, Perissinotto C, Zierler RE, Polissar NL, Bergelin RO, Tullis MJ et al. Prospective study of atherosclerotic disease progression in the renal artery. Circulation 1998; 98: 2866-2872.
48. van Jaarsveld BC, Krijnen P, Pieterman H, Derkx FH, Deinum J, Postma CT et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch renal artery stenosis intervention cooperative study group. N Engl J Med 2000; 342: 1007-1014.
49. Weibull H, Bergqvist D, Bergentz SE, Jonsson K, Hulthen L, Manhem P. Percutaneous transluminal renal angioplasty versus surgical reconstruction of atherosclerotic renal artery stenosis: A prospective randomized study. J Vasc Surg 1993; 18: 841-50; discussion 50-52.
50. van de Ven PJG, Kaatee R, Beutler JJ, Beek FJ, Woittiez AJ, Buskens E et al. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: A randomised trial. Lancet 1999; 353: 282-286.
51. Rundback JH, Gray RJ, Rozenblit G, Poplausky MR, Babu S, Shah P et al. Renal artery stent placement for the management of ischemic nephropathy. J Vasc Interv Radiol 1998; 9: 413-420.
52. Eldrup-Jorgensen J, Harvey HR, Sampson LN, Amberson SM, Bredenberg CE. Should percutaneous transluminal renal artery angioplasty be applied to ostial renal artery atherosclerosis? J Vasc Surg 1995; 21: 909-14; discussion 14-15.
53. Martinez-Amenos A, Rama H, Sarrias X, Galceran J, Alsina J, Montanya X. Percutaneous transluminal angioplasty in the treatment of renovascular hypertension. J Hum Hypertens 1991; 5: 97-100.
54. Feest TG, Mistry CD, Grimes DS, Mallick NP. Incidence of advanced chronic renal failure and the need for end stage renal replacement treatment. BMJ 1990; 301: 897-900.
55. Olin JW, Melia M, Young JR, Graor RA, Risius B. Prevalence of atherosclerotic renal artery stenosis in patients with atherosclerosis elsewhere. Am J Med 1990; 88: 46N-51N.
56. Vetrovec GW, Landwehr DM, Edwards VL. Incidence of renal artery stenosis in hypertensive patients undergoing coronary arteriography. J Interven Cardiol 1989; 2: 69-76.
57. Ramirez G, Bugni WSMF, Curry AJ. Incidence of renal artery stenosis in a population undergoing cardiac catheterisation. South Med J 1987; 80: 734-737.
58. Harding MB, Smith LR, Himmelstein SI, Harrison K, Phillips HR, Schwab SJ et al. Renal artery stenosis: Prevalence and associated risk factors in patients undergoing routine cardiac catheterisation. J Am Soc Nephrol 1992; 2: 1608-1616.